Table 1:
Characteristic | No. of patients (%) N = 50 |
---|---|
Median age at diagnosis, years (IQR) | 53 (42, 64) |
Race | |
White | 39 (78%) |
Black or African American | 3 (6%) |
Asian | 6 (12%) |
Unknown | 2 (4 %) |
Median BMI at diagnosis, kg/m2 (IQR) | 25 (22, 29) |
Stage at diagnosis | |
III | 39 (78%) |
IV | 11 (22%) |
KRAS profiling | |
KRAS wild type | 24 (80%) |
KRAS mutation | 6 (20%) |
Unknown | 20 |
Postoperative residual tumor | |
Complete gross resection | 26 (55%) |
Optimal (≤1 cm) | 14 (30%) |
Suboptimal (>1 cm) | 7 (15%) |
No surgery/unknown | 3 |
Surgical procedure performed beyond standard staging * | |
Bowel resections | 24 (50%) |
Upper abdominal procedures | 21 (44%) |
Major urologic procedures | 2 (4%) |
IQR, interquartile range; BMI, body mass index
Denominator is patients who underwent surgery, n=48